130 related articles for article (PubMed ID: 7855972)
1. Long-term experience utilizing a new balloon expandable prostatic endoprosthesis: the Titan stent. North American Titan Stent Study Group.
Kaplan SA; Chiou RK; Morton WJ; Katz PG
Urology; 1995 Feb; 45(2):234-40. PubMed ID: 7855972
[TBL] [Abstract][Full Text] [Related]
2. The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group.
Oesterling JE; Kaplan SA; Epstein HB; Defalco AJ; Reddy PK; Chancellor MB
Urology; 1994 Sep; 44(3):353-62. PubMed ID: 7521091
[TBL] [Abstract][Full Text] [Related]
3. Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia.
Kaplan SA; Te AE
Urology; 1995 Apr; 45(4):566-72. PubMed ID: 7536365
[TBL] [Abstract][Full Text] [Related]
4. The titanium intraprostatic stent: the United States experience.
Kaplan SA; Merrill DC; Mosely WG; Benson RC; Chiou RK; Fuselier HA; Parra RO
J Urol; 1993 Nov; 150(5 Pt 2):1624-9. PubMed ID: 7692099
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of prostatic stent treatment for benign prostatic hyperplasia.
Chiou RK; Chen WS; Akbari A; Foley S; Lynch B; Taylor RJ
Urology; 1996 Oct; 48(4):589-93. PubMed ID: 8886065
[TBL] [Abstract][Full Text] [Related]
6. Thermo-expandable intraprostatic stents in bladder outlet obstruction: an 8-year study.
Perry MJ; Roodhouse AJ; Gidlow AB; Spicer TG; Ellis BW
BJU Int; 2002 Aug; 90(3):216-23. PubMed ID: 12133055
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of reduction cystoplasty in men with impaired detrusor contractility.
Thorner DA; Blaivas JG; Tsui JF; Kashan MY; Weinberger JM; Weiss JP
Urology; 2014 Apr; 83(4):882-6. PubMed ID: 24548706
[TBL] [Abstract][Full Text] [Related]
8. Management of intractable bladder neck strictures following radical prostatectomy using the Memokath
Nathan A; Mazzon G; Pavan N; De Groote R; Sridhar A; Nathan S
J Robot Surg; 2020 Aug; 14(4):621-625. PubMed ID: 31617064
[TBL] [Abstract][Full Text] [Related]
9. Transurethral vaporization of the prostate in the treatment of bladder outlet obstruction at two university hospitals.
Gerber GS; Jahoda A; Bales GT; Albala DM
Tech Urol; 1997; 3(1):25-9. PubMed ID: 9170221
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia.
Cowles RS; Kabalin JN; Childs S; Lepor H; Dixon C; Stein B; Zabbo A
Urology; 1995 Aug; 46(2):155-60. PubMed ID: 7542818
[TBL] [Abstract][Full Text] [Related]
11. Feedback microwave thermotherapy with the ProstaLund Compact Device for obstructive benign prostatic hyperplasia: 12-month response rates and complications.
Alivizatos G; Ferakis N; Mitropoulos D; Skolarikos A; Livadas K; Kastriotis I
J Endourol; 2005; 19(1):72-8. PubMed ID: 15735388
[TBL] [Abstract][Full Text] [Related]
12. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
Utomo E; Groen J; Blok BF
Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
[TBL] [Abstract][Full Text] [Related]
13. Experience with the Memotherm permanently implanted prostatic stent.
Williams G; White R
Br J Urol; 1995 Sep; 76(3):337-40. PubMed ID: 7551842
[TBL] [Abstract][Full Text] [Related]
14. Photoselective laser vaporization of the prostate in the treatment of bladder outlet obstruction in advanced-stage prostate cancer: a single-center experience.
Jin C; Xu YM; Fu Q; Gu B
J Endourol; 2012 Oct; 26(10):1314-8. PubMed ID: 22563737
[TBL] [Abstract][Full Text] [Related]
15. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial.
Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA; Malek RS
J Urol; 2004 Oct; 172(4 Pt 1):1404-8. PubMed ID: 15371855
[TBL] [Abstract][Full Text] [Related]
16. Hourglass-shaped nitinol prostatic stent in treatment of patients with lower urinary tract symptoms due to bladder outlet obstruction.
van Dijk MM; Mochtar CA; Wijkstra H; Laguna MP; de la Rosette JJ
Urology; 2005 Oct; 66(4):845-9. PubMed ID: 16230150
[TBL] [Abstract][Full Text] [Related]
17. A novel temporary prostatic stent for the relief of prostatic urethral obstruction.
Corica AP; Larson BT; Sagaz A; Corica AG; Larson TR
BJU Int; 2004 Feb; 93(3):346-8. PubMed ID: 14764134
[TBL] [Abstract][Full Text] [Related]
18. Postvoid residual urine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: pooled analysis of eleven controlled studies with alfuzosin.
McNeill SA; Hargreave TB; Geffriaud-Ricouard C; Santoni J; Roehrborn CG
Urology; 2001 Mar; 57(3):459-65. PubMed ID: 11248620
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the clinical value of a simple flowmeter in the management of male lower urinary tract symptoms.
Chan CK; Yip SK; Wu IP; Li ML; Chan NH
BJU Int; 2012 Jun; 109(11):1690-6. PubMed ID: 21933332
[TBL] [Abstract][Full Text] [Related]
20. Holmium laser enucleation of the prostate combined with mechanical morcellation: two years of experience with 196 patients.
Vavassori I; Hurle R; Vismara A; Manzetti A; Valenti S
J Endourol; 2004 Feb; 18(1):109-12. PubMed ID: 15006063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
